Experimental animal models of chronic inflammatory conditions such as posterior uveitis, psoriasis, inflammatory bowel disease, multiple sclerosis, collagen-induced arthritis, and ankylosing spondylitis have highlighted the significant pathogenic impact of IL-17A [44]. Here, IL17A is linked to posterior uveitis.